Trial NCT00848107

View at ClinicalTrials.gov 
Org. Study IDs: TDE-DU-202

Last trial update was posted on 2014-02-07

MeSH Interventions

Treprostinil

MeSH Conditions

Scleroderma, Diffuse Scleroderma, Systemic Sclerosis

Other Conditions

Systemic Sclerosis

Stopping Reasons

The TDE-DU-202 extension study was discontinued after the randomized, placebo-controlled TDE-DU-201 study did not meet its primary efficacy objective.

Limitations And Caveats

Interpretation of the change in digital ulcer status was limited by the lack of a control group and the discontinuation of the study prior to subjects completing all scheduled visits.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID